Literature DB >> 23529671

Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia.

Aysegul Atmaca1, Birsen Bilgici, Gulcin Cengiz Ecemis, Ozgur Korhan Tuncel.   

Abstract

The effects of hyperprolactinemia on metabolic parameters are not clear and a few data evaluating adiponectin levels in prolactinoma and idiopathic hyperprolactinemia exist. The aim of this study was to evaluate the effects of hyperprolactinemia on body weight, insulin resistance, beta cell function, and leptin and adiponectin levels in premenopausal women with hyperprolactinemia. Forty premenopausal women with prolactinoma or idiopathic hyperprolactinemia were compared to 41 age-matched healthy premenopausal women with regard to body weight, body mass index, waist and hip circumferences, waist to hip ratio, fasting plasma glucose, insulin levels, insulin resistance measured by homeostasis model assessment (HOMA)-insulin resistance index, beta cell function measured by HOMA-β index, leptin and adiponectin levels. Plasma insulin levels and HOMA indexes (both insulin resistance and beta indexes) were significantly higher in hyperprolactinemic women. The other parameters were similar between both groups. There was a positive correlation between prolactin levels and fasting plasma glucose in hyperprolactinemic women. The results of this study showed that high prolactin levels may be associated with hyperinsulinemia and insulin resistance in premenopausal women. This effect seems to be independent of body weight, leptin and adiponectin levels. High prolactin levels may directly stimulate insulin secretion from pancreas and directly cause hepatic and whole-body insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529671     DOI: 10.1007/s12020-013-9931-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  37 in total

1.  Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue.

Authors:  Louise Nilsson; Nadine Binart; Mohammad Bohlooly-Y; Margareta Bramnert; Emil Egecioglu; Jon Kindblom; Paul A Kelly; John J Kopchick; Christopher J Ormandy; Charlotte Ling; Håkan Billig
Journal:  Biochem Biophys Res Commun       Date:  2005-06-17       Impact factor: 3.575

2.  Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats.

Authors:  Sunmin Park; Da Sol Kim; James W Daily; Sung-Hoon Kim
Journal:  Diabetes Metab Res Rev       Date:  2011-09       Impact factor: 4.876

3.  LS14: a novel human adipocyte cell line that produces prolactin.

Authors:  Eric R Hugo; Terry D Brandebourg; Clay E S Comstock; Keith S Gersin; Jeffrey J Sussman; Nira Ben-Jonathan
Journal:  Endocrinology       Date:  2005-09-29       Impact factor: 4.736

4.  Brain dopamine and obesity.

Authors:  G J Wang; N D Volkow; J Logan; N R Pappas; C T Wong; W Zhu; N Netusil; J S Fowler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

5.  Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.

Authors:  Shelley S Tworoger; Christos Mantzoros; Susan E Hankinson
Journal:  Obesity (Silver Spring)       Date:  2007-09       Impact factor: 5.002

Review 6.  The effects of hyperprolactinemia on bone and fat.

Authors:  Amal Shibli-Rahhal; Janet Schlechte
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 7.  Adipocyte prolactin: regulation of release and putative functions.

Authors:  T Brandebourg; E Hugo; N Ben-Jonathan
Journal:  Diabetes Obes Metab       Date:  2007-07       Impact factor: 6.577

8.  Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.

Authors:  G Schernthaner; R Prager; C Punzengruber; A Luger
Journal:  Diabetologia       Date:  1985-03       Impact factor: 10.122

Review 9.  Immunomodulatory role of prolactin in diabetes development.

Authors:  P Cejkova; M Fojtikova; M Cerna
Journal:  Autoimmun Rev       Date:  2009-02-25       Impact factor: 9.754

10.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  5 in total

Review 1.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

2.  Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas.

Authors:  Rita Indirli; Emanuele Ferrante; Elisa Sala; Claudia Giavoli; Giovanna Mantovani; Maura Arosio
Journal:  Horm Cancer       Date:  2019-04-18       Impact factor: 3.869

Review 3.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

Review 4.  Metabolic effects of prolactin.

Authors:  Rosa Pirchio; Chiara Graziadio; Annamaria Colao; Rosario Pivonello; Renata S Auriemma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

5.  Plasma Prolactin and Progesterone Levels and the Risk of Gestational Diabetes: A Prospective and Longitudinal Study in a Multiracial Cohort.

Authors:  Mengying Li; Yiqing Song; Shristi Rawal; Stefanie N Hinkle; Yeyi Zhu; Fasil Tekola-Ayele; Assiamira Ferrara; Michael Y Tsai; Cuilin Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-27       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.